Bioidentical Hormone Therapy for General Health and Wellness
Bioidentical hormone therapy should NOT be used for general health and wellness purposes in postmenopausal women. The U.S. Preventive Services Task Force explicitly recommends against routine hormone therapy for primary prevention of chronic conditions, and the FDA has not approved any bioidentical hormone therapy for disease prevention 1.
Key Evidence Against Use for Wellness
Regulatory and Safety Status
Custom-compounded "bioidentical hormone therapy" is not recommended 2. According to the USPSTF, "bioidentical hormone replacement therapy" is a marketing term rather than a formally defined drug classification 1. The FDA has not approved any type or class of bioidentical hormone therapy for prevention of chronic diseases, and no randomized trials have studied their potential benefits or harms for chronic disease prevention 1.
The American College of Obstetricians and Gynecologists states that compounded bioidentical preparations should not be prescribed routinely when FDA-approved formulations exist, as evidence supporting marketing claims of safety and effectiveness is lacking 3.
Harm-Benefit Profile for Disease Prevention
The USPSTF reviewed extensive evidence and found that harms exceed benefits for disease prevention 1, 4. For every 10,000 women taking estrogen-progestin therapy for one year, there would be:
Harms:
- 7 additional coronary heart disease events
- 8 more strokes
- 8 more pulmonary emboli
- 8 more invasive breast cancers
Benefits:
- 6 fewer colorectal cancers
- 5 fewer hip fractures
This unfavorable balance led major organizations including the American Heart Association, American Congress of Obstetricians and Gynecologists, and American Academy of Family Physicians to recommend against hormone therapy for chronic disease prevention 1.
Specific Contraindications for "Wellness" Use
Hormone therapy should NOT be used for:
- Cardiovascular disease prevention (primary or secondary) 1, 2
- Dementia or cognitive aging prevention 1, 2
- General "anti-aging" or wellness purposes 1
When Hormone Therapy IS Appropriate
The distinction is critical: hormone therapy is appropriate ONLY for treating bothersome menopausal symptoms (hot flashes, vaginal atrophy), not for general wellness 1, 5.
Treatment Algorithm for Symptomatic Women
For women <60 years old OR <10 years past menopause with bothersome symptoms:
- FDA-approved preparations should be used over compounded products 2, 5
- Use lowest effective dose for shortest duration 4
- Transdermal estradiol preferred for women with moderate cardiovascular risk 5
- Must add progestogen if uterus present 5
For women ≥60 years old OR ≥10 years past menopause:
- Evaluate baseline cardiovascular risk before initiating 5
- Consider non-hormonal therapies first if high cardiovascular risk 5
Critical Pitfalls to Avoid
Marketing deception: Claims that compounded bioidenticals are "natural," "safer," or "more effective" lack scientific evidence 3, 6, 7
Salivary hormone testing: This is unnecessary, not standardized, and should be avoided 8
Assuming "bioidentical" means safer: Even FDA-approved bioidentical formulations carry the same risks as other hormone therapies when used for disease prevention 1
Prescribing for asymptomatic women: There is no role for hormone therapy in women without menopausal symptoms, regardless of formulation 1
Alternative Strategies for Health Optimization
For women seeking to optimize health and prevent chronic disease, clinicians should recommend evidence-based interventions 4:
- Osteoporosis screening and non-hormonal treatments
- Lipid screening and management
- Blood pressure control
- Smoking cessation
- Weight-bearing exercise
- Adequate calcium and vitamin D
- Breast and colorectal cancer screening
The bottom line: Bioidentical hormones have no validated role in health and wellness for asymptomatic women and carry significant risks when used for disease prevention.